Literature DB >> 24006929

The changing epidemiology of β-thalassemia in the Greek-Cypriot population.

Andreani R Kyrri1, Eleni Kalogerou, Dena Loizidou, Christina Ioannou, Christina Makariou, Loukas Kythreotis, Marios Phylactides, Petros Kountouris, Michael Angastiniotis, Bernadette Modell, Marina Kleanthous.   

Abstract

The first epidemiological study for thalassemia in Cyprus was performed by Fawdry in 1946. The study determined that the frequency of β-thalassemia (β-thal) carriers was around 18.0% and that of α(0)-thal carriers (individuals with both cis α-globin genes inactive) at around 2.0%. In 1998, another study concluded that Cyprus had one of the highest frequencies of β-thal carriers worldwide (17.2%). Based on Haldane's hypothesis that malaria might be the selective agent responsible for the maintenance of high levels of thalassemia and sickle cell disease in many populations around the world, it is expected that following the eradication of the disease in Cyprus in 1948, the carriers of β-thal should decline with each generation. In order to determine whether this has been the case, we compiled frequency data for β-thal carriers from three separate surveys performed as part of the Cyprus National Thalassaemia Screening Programme (NTSP). The surveys were carried out in 1986, 2003 and 2010 involving 9622, 6711 and 5228 subjects, respectively. The expected drop in the prevalence of β-thal carriers for each successive generation following the eradication of malaria, i.e., in the absence of selection pressure, was calculated using the Hardy-Weinberg equation and the mathematical model of Hartl and Clark. The surveys provide supporting evidence for the decrease of the frequency of the β-thal carriers in the Greek Cypriot population, with a drop of 1.89% in 24 years.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24006929     DOI: 10.3109/03630269.2013.801851

Source DB:  PubMed          Journal:  Hemoglobin        ISSN: 0363-0269            Impact factor:   0.849


  4 in total

1.  Next generation sequencing of SNPs for non-invasive prenatal diagnosis: challenges and feasibility as illustrated by an application to β-thalassaemia.

Authors:  Thessalia Papasavva; Wilfred F J van Ijcken; Christel E M Kockx; Mirjam C G N van den Hout; Petros Kountouris; Loukas Kythreotis; Eleni Kalogirou; Frank G Grosveld; Marina Kleanthous
Journal:  Eur J Hum Genet       Date:  2013-04-10       Impact factor: 4.246

2.  Prevalence of Thalassemia Trait & Iron Deficiency Anemia during Infancy in 2011-2013 in a Thalassemia Prevalent Region: North Cyprus.

Authors:  Burçin Şanlidağ; Buse Çağin; Övgü Özenli; Özlem Şahaloğlu; Ceyhun Dalkan; Nilüfer Galip; Arzu Babayiğit Hocaoğlu; Nerin Bahçeciler
Journal:  Iran J Public Health       Date:  2016-08       Impact factor: 1.429

3.  The molecular spectrum and distribution of haemoglobinopathies in Cyprus: a 20-year retrospective study.

Authors:  Petros Kountouris; Ioanna Kousiappa; Thessalia Papasavva; George Christopoulos; Eleni Pavlou; Miranda Petrou; Xenia Feleki; Eleni Karitzie; Marios Phylactides; Pavlos Fanis; Carsten W Lederer; Andreani R Kyrri; Eleni Kalogerou; Christiana Makariou; Christiana Ioannou; Loukas Kythreotis; Georgia Hadjilambi; Nicoletta Andreou; Evangelia Pangalou; Irene Savvidou; Michael Angastiniotis; Michael Hadjigavriel; Maria Sitarou; Annita Kolnagou; Marina Kleanthous; Soteroula Christou
Journal:  Sci Rep       Date:  2016-05-20       Impact factor: 4.379

4.  Fast Temperature-Gradient COLD PCR for the enrichment of the paternally inherited SNPs in cell free fetal DNA; an application to non-invasive prenatal diagnosis of β-thalassaemia.

Authors:  Stefania Byrou; G Mike Makrigiorgos; Agathoklis Christofides; Ioannis Kallikas; Thessalia Papasavva; Marina Kleanthous
Journal:  PLoS One       Date:  2018-07-25       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.